This UnitedHealth Group Analyst Is No Longer Bullish; Right here Are High 5 Downgrades For Wednesday – Artelo Biosciences (NASDAQ:ARTL), BILL Holdings (NYSE:BILL)

High Wall Avenue analysts modified their outlook on these high names. For an entire view of all analyst ranking adjustments, together with upgrades, downgrades and initiations, please see our analyst scores web page.

Jefferies analyst Julien Dumoulin-Smith downgraded Sunrun Inc. RUN from Maintain to Underperform and lowered the worth goal from $6 to $5. Sunrun shares closed at $8.86 on Tuesday. See how different analysts view this inventory.
Baird analyst Michael Ha downgraded the ranking for UnitedHealth Group Integrated UNH from Outperform to Impartial and lowered the worth goal from $356 to $312. UnitedHealth shares closed at $303.79 on Tuesday. See how different analysts view this inventory.
Goldman Sachs analyst Kash Rangan downgraded GitLab Inc. GTLB from Purchase to Impartial and lower the worth goal from $63 to $50. GitLab shares closed at $48.51 on Tuesday. See how different analysts view this inventory.
Morgan Stanley analyst Keith Weiss downgraded BILL Holdings, Inc. BILL from Chubby to Equal-Weight and lowered the worth goal from $60 to $55. BILL Holdings shares closed at $45.37 on Tuesday. See how different analysts view this inventory.
D. Boral Capital analyst Jason Kolbert downgraded the ranking for Artelo Biosciences, Inc. ARTL from Purchase to Maintain. Artelo Biosciences shares closed at $1.13 on Tuesday. See how different analysts view this inventory.

Contemplating shopping for UNH inventory? Right here’s what analysts assume:

Huge Demand & Disruptive Potential – Boxabl has acquired curiosity for over 190,000 properties, positioning itself as a serious disruptor within the housing market.
Revolutionary Manufacturing Method – Impressed by Henry Ford’s meeting line, Boxabl’s foldable tiny properties are designed for high-efficiency manufacturing, making homeownership extra accessible.
Reasonably priced Funding Alternative – With properties priced at $60,000, Boxabl is elevating $1 billion to scale manufacturing, providing traders an opportunity to personal a stake in its development.